Evaluation of pathogen distribution and antimicrobial resistance in breast plastic surgery infection.
Abstract
[BACKGROUND] The demand for mammaplasty has increased in recent years, and infection remains one of the common and serious post-operative complications. In this study, we analyzed the pathogen distribution and antibiotic susceptibility of breast plastic surgery infections, and compared the differences in pathogenic species between surgical procedures.
[METHODS] The number of each species was counted in the microbial samples of breast plastic surgery infections in Plastic Surgery Hospital of Chinese Academy of Medical Sciences from January 2011 to December 2021. The in vitro antibiotic sensitivity testing data were analyzed using WHONET 5.6 software. The surgical techniques, the period of infection, and other details were gathered in accordance with the clinical data.
[RESULTS] There were a total of 42 cases included, and 43 different types of pathogenic bacteria, mostly gram-positive bacteria, were found. CoNS (13/43) and Staphylococcus aureus (22/43) made up the majority. The most prevalent of the five Gram-negative bacteria was Pseudomonas aeruginosa. Results of drug sensitivity tests indicate that S. aureus is highly sensitive to vancomycin, cotrimoxazole, and linezolid, whereas CoNS is highly sensitive to vancomycin, linezolid, and chloramphenicol. Both of these bacteria show high resistance to erythromycin and penicillin. Breast augmentation, breast reconstruction, and breast reduction surgery were the most frequently associated breast surgery procedures in this study with infections, with the highest number of infections occurring following breast augmentation with fat grafting, breast reduction surgery, and breast reconstruction with autologous tissue. Various breast plastic surgery procedures have different common pathogens of infection, but the most prevalent are CoNS and S. aureus. Additionally, the majority of the infections in this study were in the early stages.
[CONCLUSIONS] Gram-positive bacteria were the predominant cause of breast plastic surgery infections, and the types of infection strains, the period of infection onset, and the antibiotic susceptibility of prevalent strains varied between breast plastic procedures.
[METHODS] The number of each species was counted in the microbial samples of breast plastic surgery infections in Plastic Surgery Hospital of Chinese Academy of Medical Sciences from January 2011 to December 2021. The in vitro antibiotic sensitivity testing data were analyzed using WHONET 5.6 software. The surgical techniques, the period of infection, and other details were gathered in accordance with the clinical data.
[RESULTS] There were a total of 42 cases included, and 43 different types of pathogenic bacteria, mostly gram-positive bacteria, were found. CoNS (13/43) and Staphylococcus aureus (22/43) made up the majority. The most prevalent of the five Gram-negative bacteria was Pseudomonas aeruginosa. Results of drug sensitivity tests indicate that S. aureus is highly sensitive to vancomycin, cotrimoxazole, and linezolid, whereas CoNS is highly sensitive to vancomycin, linezolid, and chloramphenicol. Both of these bacteria show high resistance to erythromycin and penicillin. Breast augmentation, breast reconstruction, and breast reduction surgery were the most frequently associated breast surgery procedures in this study with infections, with the highest number of infections occurring following breast augmentation with fat grafting, breast reduction surgery, and breast reconstruction with autologous tissue. Various breast plastic surgery procedures have different common pathogens of infection, but the most prevalent are CoNS and S. aureus. Additionally, the majority of the infections in this study were in the early stages.
[CONCLUSIONS] Gram-positive bacteria were the predominant cause of breast plastic surgery infections, and the types of infection strains, the period of infection onset, and the antibiotic susceptibility of prevalent strains varied between breast plastic procedures.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | breast
|
유방 | dict | 13 | |
| 합병증 | infection
|
감염 | dict | 6 | |
| 시술 | breast augmentation
|
유방성형술 | dict | 2 | |
| 시술 | breast reduction
|
유방성형술 | dict | 2 | |
| 시술 | mammaplasty
|
유방성형술 | dict | 1 | |
| 해부 | fat
|
scispacy | 1 | ||
| 해부 | tissue
|
scispacy | 1 | ||
| 해부 | S. aureus
|
scispacy | 1 | ||
| 약물 | vancomycin
|
C0042313
vancomycin
|
scispacy | 1 | |
| 약물 | cotrimoxazole
|
C0041044
Trimethoprim-Sulfamethoxazole Combination
|
scispacy | 1 | |
| 약물 | linezolid
|
C0663241
linezolid
|
scispacy | 1 | |
| 약물 | chloramphenicol
|
C0008168
chloramphenicol
|
scispacy | 1 | |
| 약물 | erythromycin
|
C0014806
erythromycin
|
scispacy | 1 | |
| 약물 | penicillin
|
C0030842
penicillins
|
scispacy | 1 | |
| 약물 | [BACKGROUND]
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] Gram-positive
|
scispacy | 1 | ||
| 질환 | infections
|
C0851162
Infections of musculoskeletal system
|
scispacy | 1 | |
| 질환 | aeruginosa
|
C0033809
Pseudomonas aeruginosa
|
scispacy | 1 | |
| 질환 | S. aureus
|
C0038172
Staphylococcus aureus
|
scispacy | 1 | |
| 질환 | breast plastic
|
scispacy | 1 | ||
| 질환 | breast plastic surgery infections
|
scispacy | 1 | ||
| 질환 | breast plastic surgery procedures have different
|
scispacy | 1 | ||
| 기타 | CoNS
|
scispacy | 1 |
MeSH Terms
Female; Humans; Anti-Bacterial Agents; Staphylococcus aureus; Surgery, Plastic; Linezolid; Vancomycin; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Gram-Positive Bacteria; Mammaplasty; Retrospective Studies
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.